About Pharmacosmos

Pharmacosmos develops and markets medicines for the treatment of iron deficiency - and is the developer of Monofer

Pharmacosmos develops and markets medicines for the treatment of iron deficiency. We are located in Holbaek, Denmark, where our product development and pharmaceutical production take place.

An independent pharmaceutical company with an ongoing R&D programme, our goal is to improve treatment options for healthcare professionals and patients - and we work with exclusive partners in more than 50 countries worldwide.

Specialists in intravenous iron therapy, we recently developed and received approval for Monofer (iron isomaltoside 1000), a treatment of iron deficiency anaemia for patients with various underlying conditions.

To learn more about Pharmacosmos, we invite you to visit Pharmacosmos.com